Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in:

01.08.2015 | Original Article

Morbidity reduction using the vessel sealing device LigaSure™ in breast cancer surgery

verfasst von: P. Panhofer, MD, MBA, S. Rothe, MBA, M. Schütz, MD, B. Grohmann-Izay, MD, P. Dubsky, MD, R. Jakesz, MD, M. Gnant, MD, F. Fitzal, MD

Erschienen in: European Surgery | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Summary

Background

Seroma formation is the major morbidity nuisance after breast cancer surgery. It prolonges hospital stay and causes infections and wound healing problems. The aim of the study was to evaluate the impact of the vessel sealing device LigaSure™ on postoperative morbidity especially seroma formation.

Methods

Between 2011 and 2012, data were retrospectively evaluated from 59 women with breast cancer who underwent axillary dissection at a university hospital. The Clavien Dindo Classification (CDC) was used to assess the severity of postoperative complications. Surgery was performed with LigaSure™ in 23 patients (39.0 %) compared with monopolar electrocautery in the control group.

Results

A total of 36 patients (61.0 %) had breast conserving surgery, and 5 patients (8.5 %) underwent isolated axillary dissection. Morbidity-associated re-operations were reported in 5.1 %. Seroma rates were nearly twice as high in the control group compared with LigaSure™ patients (p = 0.056). Hospital stay was shortened by 1 day using LigaSure™. The rate of punctures at the outpatient ward was half as high in the LigaSure™ cohort (21.7 vs. 41.7 %; p = 0.115). The frequency of aspirations (≤ 2 times) was lower in LigaSure™ patients. Despite this, the median puncture volume was higher (195 ml; IQR: 112.5–265 ml) in the LigaSure™ cohort as compared with the control group (100 ml; IQR: 60–180 ml). Overall, the CDC was significantly lower in the LigaSure™ group compared with the conventional cohort (p = 0.038).

Conclusions

The vessel sealing device LigaSure™ leads to a reduction of postoperative morbidity, hospital stay, and puncture frequency, which is desirable in terms of cost-effectiveness.
Vorheriger Artikel Is there: surgery goes inter- and multidisciplinary
Nächster Artikel Patch, interposition graft or stent for treatment of restenosis after carotid endarterectomy: a retrospective study
Literatur
1.
Panhofer P, Ferenc V, Schütz M, et al. Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo Classification. Int J Surg. 2014;12(4):334–9. doi:10.1016/j.ijsu.2014.01.012.PubMedCrossRef
2.
Cortadellas T, Córdoba O, Espinosa-Bravo M, et al. Electrothermal bipolar vessel sealing system in axillary dissection: a prospective randomized clinical study. Int J Surg. 2011;9(8):636–40. doi:10.1016/j.ijsu.2011.08.002.PubMedCrossRef
3.
Van Bemmel AJ, van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol. 2011;37(10):829–35. doi:10.1016/j.ejso.2011.04.012.PubMedCrossRef
4.
Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. Breast. 2003;12(5):338–41.PubMedCrossRef
5.
Burak WE Jr., Goodman PS, Young DC, Farrar WB. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol. 1997;64(1):27–31.PubMedCrossRef
6.
Schuijtvlot M, Sahu AK, Cawthorn SJ. A prospective audit of the use of a buttress suture to reduce seroma formation following axillary node dissection without drains. Breast. 2002;11(1):94–6.PubMedCrossRef
7.
Gong Y, Xu J, Shao J, et al. Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: a randomized trial. Am J Surg. 2010;200(3):352–6. doi:10.1016/j.amjsurg.2009.10.013.PubMedCrossRef
8.
Carless PA, Henry DA. Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. Br J Surg. 2006;93(7):810–9.PubMedCrossRef
9.
Moore M, Burak WE Jr., Nelson E, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg. 2001;192(5):591–9.PubMedCrossRef
10.
Sanders RP, Goodman NC, Amiss LR Jr., et al. Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention. J Surg Res. 1996;61(1):65–70.PubMedCrossRef
11.
Warren HW, Griffith CD, McLean L, Angerson WJ, Kaye B, McElroy M. Should breast biopsy cavities be drained? Ann R Coll Surg Engl. 1994;76(1):39–41.PubMedCentralPubMed
12.
Zavotsky J, Jones RC, Brennan MB, Giuliano AE. Evaluation of axillary lymphadenectomy without axillary drainage for patients undergoing breast-conserving therapy. Ann Surg Oncol. 1998;5(3):227–31.PubMedCrossRef
13.
Somers RG, Jablon LK, Kaplan MJ, Sandler GL, Rosenblatt NK. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial. Ann Surg. 1992;215(2):146–9.PubMedCentralPubMedCrossRef
14.
Jansen RF, van Geel AN, de Groot HG, Rottier AB, Olthuis GA, van Putten WL. Immediate versus delayed shoulder exercises after axillary lymph node dissection. Am J Surg. 1990;160(5):481–4.PubMedCrossRef
15.
Rice DC, Morris SM, Sarr MG, et al. Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. J Surg Oncol. 2000;73(4):224–7.PubMedCrossRef
16.
Carcoforo P, Soliani G, Maestroni U, et al. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. J Am Coll Surg. 2003;196(3):365–9.PubMedCrossRef
17.
Porter KA, O’Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg. 1998;176(1):8–11.PubMedCrossRef
18.
Keogh GW, Doughty JC, McArdle CSM, Cooke TG. Seroma formation related to electrocautery in breast surgery: a prospective randomized trial. Breast. 1998;7(1):39–41.CrossRef
19.
Hoefer RA Jr., DuBois JJ, Ostrow LB, Silver LF. Wound complications following modified radical mastectomy: an analysis of perioperative factors. J Am Osteopath Assoc. 1990;90(1):47–53.PubMed
20.
Deo SV, Shukla NK. Modified radical mastectomy using harmonic scalpel. J Surg Oncol. 2000;74(3):204–7.PubMedCrossRef
21.
Lumachi F, Brandes AA, Burelli P, Basso SM, Iacobone M, Ermani M. Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study. Eur J Surg Oncol. 2004;30(5):526–30.PubMedCrossRef
22.
Antonio M, Pietra T, Domenico L, et al. Does LigaSure reduce fluid drainage in axillary dissection? A randomized prospective clinical trial. Ecancermedicalscience. 2007;1:61. doi:10.3332/eCMS.2007.61.PubMedCentralPubMed
23.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.PubMedCentralPubMedCrossRef
24.
Steger GG, Galid A, Gnant M, et al. Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14. J Clin Oncol. 2007;25(15):2012–8.PubMedCrossRef
25.
Steger GG, Greil R, Lang A, et al. Austrian Breast and Colorectal Study Group (ABCSG), Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). Ann Oncol. 2014;25(2):366–71. doi:10.1093/annonc/mdt508.PubMedCrossRef
26.
Morrow M. Margins in breast-conserving therapy: have we lost sight of the big picture? Expert Rev Anticancer Ther. 2008;8(8):1193–6. doi:10.1586/14737140.8.8.1193.PubMedCrossRef
27.
Fitzal F, Nehrer G, Hoch D, et al. An oncoplastic procedure for central and medio-cranial breast cancer. Eur J Surg Oncol. 2007;33(10):1158–63.PubMedCrossRef
28.
Puttawibul P, Sangthong B, Maipang T, Sampao S, Uttamakul P, Apakupakul N. Mastectomy without drain at pectoral area: a randomized controlled trial. J Med Assoc Thai. 2003;86(4):325–31.PubMed
29.
Van Heurn LW, Brink PR. Prospective randomized trial of high versus low vacuum drainage after axillary lymphadenectomy. Br J Surg. 1995;82(7):931–2.PubMedCrossRef
30.
Droeser RA, Frey DM, Oertli D, et al. Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: a meta-analysis. Breast. 2009;18(2):109–14. doi:10.1016/j.breast.2009.02.003.PubMedCrossRef
31.
Gupta R, Pate K, Varshney S, Goddard J, Royle GT. A comparison of 5-day and 8-day drainage following mastectomy and axillary clearance. Eur J Surg Oncol. 2001;27(1):26–30.PubMedCrossRef
32.
Lumachi F, Basso SM, Santeufemia DA, Bonamini M, Chiara GB. Ultrasonic dissection system technology in breast cancer: a case-control study in a large cohort of patients requiring axillary dissection. Breast Cancer Res Treat. 2013;142(2):399–404. doi:10.1007/s10549-013-2746-0.PubMedCrossRef
33.
Sanguinetti A, Docimo G, Ragusa M, et al. Ultrasound scissors versus electrocautery in axillary dissection: our experience. G Chir. 2010;31(4):151–3.PubMed
34.
Ridings P, Bailey C, Bucknall TE. Argon beam coagulation as an adjunct in breast-conserving surgery. Ann R Coll Surg Engl. 1998;80(1):61–2.PubMedCentralPubMed
35.
Böhm D, Kubitza A, Lebrecht A, et al. Prospective randomized comparison of conventional instruments and the Harmonic Focus(®) device in breast-conserving therapy for primary breast cancer. Eur J Surg Oncol. 2012;38(2):118–24. doi:10.1016/j.ejso.2011.11.003.PubMedCrossRef
36.
Adwani A, Ebbs SR. Ultracision reduces acute blood loss but not seroma formation after mastectomy and axillary dissection: a pilot study. Int J Clin Pract. 2006;60(5):562–4.PubMedCrossRef
37.
Manouras A, Markogiannakis H, Genetzakis M, et al. Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg. 2008;143(6):575–80. doi:10.1001/archsurg.143.6.575.PubMedCrossRef
38.
Lumachi F, Burelli P, Basso SM, Iacobone M, Ermani M. Usefulness of ultrasound scissors in reducing serous drainage after axillary dissection for breast cancer: a prospective randomized clinical study. Am Surg. 2004;70(1):80–4.PubMed
39.
Lamberton GR, Hsi RS, Jin DH, Lindler TU, Jellison FC, Baldwin DD. Prospective comparison of four laparoscopic vessel ligation devices. J Endourol. 2008;22(10):2307–12. doi:10.1089/end.2008.9715.PubMedCrossRef
Metadaten
Titel
Morbidity reduction using the vessel sealing device LigaSure™ in breast cancer surgery
verfasst von
P. Panhofer, MD, MBA
S. Rothe, MBA
M. Schütz, MD
B. Grohmann-Izay, MD
P. Dubsky, MD
R. Jakesz, MD
M. Gnant, MD
F. Fitzal, MD
Publikationsdatum
01.08.2015
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 4/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0334-8

Weitere Artikel der Ausgabe 4/2015

Bilateral superficial cervical plexus block combined with bilateral greater occipital nerve block reduces the impact of different sources of pain after thyroid surgery with less consumption of morphine-PCA: a randomized trial

  • Original Article

How to report multiple outcome metrics in virtual reality simulation

  • Short Communication

Diagnosis and treatment of benign inflammatory esophageal diseases

  • Original Article

Is there: surgery goes inter- and multidisciplinary

  • Editorial

Stent-supported percutaneous transluminal angioplasty in patients suffering from symptomatic benign or malignant central venous occlusive disease

  • Original Article

“Rendez-vous” over-the-scope endoclipping for tracheoesophageal fistula: case report and review of the literature

  • Short Communication